Top

Published in:

01-08-2010 | Review

Cytotherapy of osteonecrosis of the femoral head: a mini review

Authors: You-Shui Gao, Chang-Qing Zhang

Published in: International Orthopaedics | Issue 6/2010

Abstract

The pathogenesis and aetiology of nontraumatic osteonecrosis of the femoral head has not been revealed completely. However, with advances in stem cell research and regenerative medicine, it is believed that the onset of osteonecrosis of the femoral head probably has a cellular origin, and the possible therapy of osteonecrosis of the femoral head based on cytotherapy has great potential. In this review, the aetiology of osteonecrosis of the femoral head, animal experiments and clinical applications of cytotherapy are summarized and analysed. Current problems and future challenges are discussed.

Liberman JR, Berry DJ, Mont MA, Aaron AK, Callaghan JJ, Rayadhyaksha A, Urbaniak JR (2002) Osteonecrosis of the hip: management in the twenty-first century. J Bone Joint Surg Am 84:834–853

Liu YF, Chen WM, Lin YF, Yang RC, Lin MW, Li LH et al (2005) Type II collagen gene variants and inherited osteonecrosis of the femoral head. N Eng J Med 352:2294–2301CrossRef

Chang JK, Ho ML, Yeh CH, Chen CH, Wang GJ (2006) Osteogenic gene expression decreases in stromal cells of patients with osteonecrosis. Clin Orthop Relat Res 453:286–292CrossRefPubMed

Jones LC, Hungerford DS (2007) The pathogenesis of osteonecrosis. Instr Course Lect 56:179–196PubMed

Johannson HR, Zywiel MG, Marker DR, Jones LC, McGrath MS, Mont MA (2010) Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systemic literature review. Int Orthop doi:10.1007/s00264-010-0979-7

Vilquin JT, Rosset P (2006) Mesenchymal stem cells in bone and cartilage repair: current status. Regenerative Med 1:589–604CrossRef

Aldridge JM III, Urbaniak JR (2007) Avascular necrosis of the femoral head: role of vascularized bone grafts. Orthop Clin N Am 38:13–22CrossRef

Aldridge JM III, Urbaniak JR (2008) Free vascularized bone grafting for the treatment of osteonecrosis of the femoral head. Tech Orthop 23:44–53CrossRef

Feng Y, Wang S, Jin D, Sheng J, Chen S, Cheng X, Zhang C (2009) Free vascularised fibular grafting with Osteoset®2 demineralised bone matrix versus autograft for large osteonecrotic lesions of the femoral head. Int Orthop doi:10.1007/s00264-009-0915-x

10.

Abdallah BM, Saeed H, Kassem M (2009) Human mesenchymal stem cells: basic biology and clinical applications for bone tissue regeneration. In: Baharvand H (ed) Trends in stem cell biology and technology. Humana Press, NJ, pp 177–190CrossRef

11.

Gangji V, Hauzeur JP (2009) Cellular-based therapy for osteonecrosis. Orthop Clin N Am 40:213–221CrossRef

12.

Crovace A, Favia A, Lacitignola L, Di Comite MS, Staffieri F, Francioso E (2008) Use of autologous bone marrow mononuclear cells and cultured bone marrow stromal cells in dogs with orthopaedic lesions. Vet Res Commun 32(Suppl 1):S39–S44CrossRefPubMed

13.

Sun Y, Feng Y, Zhang C (2009) The effect of bone marrow mononuclear cells on vascularization and bone regeneration in steroid-induced osteonecrosis of the femoral head. Joint Bone Spine 76:685–690CrossRefPubMed

14.

Kasten P, Beyen I, Egermann M, Suda AJ, Moghaddam AA, Zimmermann G et al (2008) Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro. Eur Cells Materials 16:47–55

15.

Lee K, Chan CK, Patil N, Goodman SB (2009) Cell therapy for bone regeneration—bench to bedside. J Biomed Mater Res B Appl Biomater 89:252–263PubMed

16.

Gangji V, Hauzeur JP, Schoutens A, Hinsenkamp M, Appelboom T, Egrise D (2003) Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol 30:348–351PubMed

17.

Lee HS, Huang GT, Chiang H, Chiou LL, Chen MH, Hsieh SH, Jiang CC (2003) Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells 21:190–199CrossRefPubMed

18.

Hernigou P, Beaujean F, Lambotte JC (1999) Decrease in the mesenchymal stem-cell pool in proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br 81:349–355CrossRefPubMed

19.

Lee JS, Lee JS, Roh HL, Kim CH, Jung JS, Suh KT (2006) Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor. J Orthop Res 24:604–609CrossRefPubMed

20.

Suh KT, Kim SW, Roh HL, Youn MS, Jung JS (2005) Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis. Clin Orthop Relat Res 431:220–225CrossRefPubMed

21.

Feng Y, Yang SH, Xiao BJ, Xu WH, Ye SN, Xia T et al (2010) Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone 46:32–40CrossRefPubMed

22.

Grellier M, Bordenave L, Amédée J (2009) Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 27:562–571CrossRefPubMed

23.

Wang Y, Wan C, Gilbert SR, Clemens TL (2007) Oxygen sensing and osteogenesis. Ann N Y Acad Sci 1117:1–11CrossRefPubMed

24.

Xue Y, Xing Z, Hellem S, Arvidson K, Mustafa K (2009) Endothelial cells influence the osteogenic potential of bone marrow stromal cells. Biomed Eng Online 8:34CrossRefPubMed

25.

Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S (2008) Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 108:18–31CrossRefPubMed

26.

Asada T, Kushida T, Umeda M, Oe K, Matsuya H, Wada T et al (2008) Prevention of corticosteroid-induced osteonecrosis in rabbits by intra-bone marrow injection of autologous bone marrow cells. Rheumatology (Oxford) 47:591–596CrossRef

27.

Yan Z, Hang D, Guo C, Chen Z (2009) Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. J Orthop Res 27:442–446CrossRefPubMed

28.

Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 405:14–23CrossRefPubMed

29.

Hernigou P, Poignard A, Zilber S, Rouard H (2008) Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop 43:40–45CrossRef

30.

Hernigou P, Zilber S, Filippini P, Rouard H, Methieu G, Poignard A (2008) Bone marrow injection in hip osteonecrosis. Tech Orthop 23:18–25CrossRef

31.

Gangji V, Bastianelli E, Toungouz M, Hauzeur J (2007) Treatment of osteonecrosis of the femoral head with implantation of preosteoblastic cells into the necrotic zone: case report. Bone 40:S47, AbstractCrossRef

32.

Wang BL, Sun W, Shi ZC, Zhang NF, Yue DB, Guo WS et al (2009) Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg doi:10.1007/s00402-009-0939-0

33.

Kang JS, Moon KH, Park SR, Kang SB, Park HB, Lee SH (2008) [Clinical results of autoiliac cancellous bone graft combined with implantation of autologous bone marrow cells for osteonecrosis of the femoral head]. J Korean Orthop Assoc 43:1–8 (in Korean)CrossRef

34.

Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi H (1998) Osteonecrosis of the femoral head: potential treatment with growth and differentiation factors. Clin Orthop Relat Res 355S:S314–S335CrossRef

35.

Liberman JR, Conduah A, Urist MR (2004) Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res 429:139–145CrossRef

36.

Suzuki O, Bishop A, Sunagawa T, Katsube K, Friedrich PF (2004) VEGF-promoted surgical angiogenesis in necrotic bone. Microsurgery 24:85–91CrossRefPubMed

37.

Xiao ZM, Jiang H, Zhan XL, Wu ZG, Zhang XL (2008) Treatment of osteonecrosis of femoral head with BMSCs-seeded bio-derived bone materials combined with rhBMP-2 in rabbits. Chin J Traumatol 11:165–170CrossRefPubMed

38.

Bajada S, Mazakova I, Richardson JB, Ashammakhi N (2008) Update on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2:169–183CrossRefPubMed

39.

Derubeis AR, Cancedda R (2004) Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann Biomed Eng 32:160–165CrossRefPubMed

40.

Kerachian MA, Séguin C, Harvey EJ (2009) Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 114:121–128CrossRefPubMed

41.

Li Y, Han R, Geng C, Wang Y, Wei L (2009) A new osteonecrosis animal model of the femoral head induced by microwave heating and repaired with tissue engineered bone. Int Orthop 33:573–580CrossRefPubMed

42.

Jackson SM, Major NM (2004) Pathologic conditions mimicking osteonecrosis. Orthop Clin N Am 35:315–320CrossRef

Title: Cytotherapy of osteonecrosis of the femoral head: a mini review
Authors: You-Shui Gao
Chang-Qing Zhang
Publication date: 01-08-2010
Publisher: Springer-Verlag
Published in: International Orthopaedics / Issue 6/2010
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-010-1009-5

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Cytotherapy of osteonecrosis of the femoral head: a mini review

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2010

Reattachment of the greater trochanter in total hip arthroplasty: the pin-sleeve system compared with the Dall-Miles cable grip system

Internal fixation of pertrochanteric fractures using DHS with a two-hole side-plate

No effect of autologous growth factors (AGF) around ungrafted loaded implants in dogs

Femoral bone density changes after total hip arthroplasty with uncemented taper-design stem: a five year follow-up study

Lesion size changes in osteonecrosis of the femoral head: a long-term prospective study using MRI

Total hip replacement as primary treatment of unstable intertrochanteric fractures in elderly patients